Home › Non-Muscle Invasive Bladder Cancer › Oregon
Non-Muscle Invasive Bladder Cancer clinical trials in Oregon
5 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in Oregon.
Cities in Oregon
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Oregon Urology Institute, Springfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06919965Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Oregon Urology Institute, Springfield
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06995677A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
- Oregon Health & Science University, Portland
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT07725796A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- OHSU Knight Cancer Institute - South Waterfront ( Site 0110), Portland
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06833073LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Oregon Health & Science University (OHSU), Portland
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT04752722From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.